Skip to main content

2nd Annual Highly Potent Active Pharmaceutical Ingredients conference

1st May 2018

Submitted by:

Andrew Warmington

The global market for highly potent active pharmaceutical ingredients is currently on a growth fast track, largely driven by its major use in oncology for cancer treatment and more often in the form of antibody drug conjugates (ADCs). Over a quarter of drugs worldwide now contain HPAPIs, as they have proven to be more effective than other APIs. 

However, working with APIs high in potency and cytotoxicity comes with many regulations and requirements, and presents pharmaceutical companies with challenges such as handling, containment, cost and security questions.

From 21-22 May 2018, SMi will present its 2nd Annual Highly Potent Active Pharmaceutical Ingredients conference at the Holiday Inn, Kensington Forum, London, UK.

The conference will cover many important and in-demand aspects of the HPAPI industry, creating a networking platform for industry professionals and key players to share their knowledge and find new innovative solutions.

This year’s Chair will be Justin Mason-Home, director of HPAPI Project Services Limited.
 

Key speakers include:

  • Ildikó Zeigler, Validation Expert, Gedeon Richter
  • Ulrich Ruemenapp, Head of Launch Preparation and Coordination, Bayer
  • Vincenzo De Sio, HPAPI Specialist, Cristália
  • Pascal Drago, Principal Technical Manager, Roche
  • Henri Motte, Head of Pilot Plant, UCB Pharma
  • Jeff Parry, Senior Scientist Manufacturability, AstraZeneca
  • Greg Sowell, Principal Scientific Manager, Genentech
     

Featured highlights

  • Discover practical approaches to HPAPI manufacturing in a controlled and efficient manner
  • Explore different containment methods and learn about which strategy best suits your needs
  • Evaluate the use of containment risk mitigation tools in early phase development
  • Learn how to manage and effectively and safely dispose of HPAPI, post-production waste
  • Discuss the most important regulations surrounding potent ingredients

View the full agenda here. 
 

Contact info:
T: +44 (0)20 7827 6048
E: [email protected]
W: www.highlypotentapi.com/specho

Helm, CAC Nantong expand partnership

Helm has reached an agreement with CAC Nantong Chemical to expand their global partnership. Under

Submitted by:

Andrew Warmington

UPL to split out specialities

Indian agrochemicals giant UPL has announced plans to transfer its speciality chemicals business, including agrochemical

Submitted by:

Andrew Warmington

AI for SAPs

Together with Algo Artis, Japan’s Nippon Shokubai has developed an algorithm-based means for the production

Submitted by:

Andrew Warmington

Sterling suite

CDMOs grow in ADCs

Reflecting the ongoing boom in the development antibody-drug conjugates (ADCs), two Western CDMOs announced expansions

Submitted by:

Andrew Warmington

Flamma Lundbeck

Flamma buys Lundbeck site

Italian CDMO Flamma has entered into an agreement to acquire Lundbeck Pharmaceuticals Italy (LuPI) from

Submitted by:

Andrew Warmington

Opening ceremony at UPM's biorefinery in Leuna

UPM opens biorefinery in Germany

UPM has inaugurated a biorefinery in Leuna, Germany, which will make up to 220,000 tonnes/year

Submitted by:

Andrew Warmington

Solenis pulp centre in Brazil

Solenis moves pulp centre

Solenis has relocated its Pulp Centre of Excellence from the US to a new facility

Submitted by:

Andrew Warmington

Milestones for two greentech firms

Afyren has achieved continuous production at its Afyren Neoxy plant at Clermont-Ferrand (pictured)

Submitted by:

Andrew Warmington

CABB in algae biorefinery deal

CABB has agreed a strategic partnership to establish a first-in-kind algae biorefinery at its site at Kokkola

Submitted by:

Andrew Warmington

First waste-based biosurfactants

Belgian start-up AmphiStar has launched what it claims are the first fully upcycled biobased surfactants

Submitted by:

Andrew Warmington

Symrise facility in India

Symrise in double Asian expansion

Symrise has announced that it has opened its new Scent Creative Centre in Singapore and

Submitted by:

Andrew Warmington

Lubrizol opens London office

Lubrizol has opened a new office in Hammersmith, London. This will be home to a

Submitted by:

Andrew Warmington

Sudarshan to buy Heubach

India’s Sudarshan Chemical Industries (SCIL) has entered into a definitive agreement to acquire the Heubach

Submitted by:

Andrew Warmington

Lanxess to continue pigment production

Lanxess has reversed a decision to sell the chromium oxide pigments business at the Krefeld-Uerdingen

Submitted by:

Andrew Warmington

Alliance in natural fragrances

Sensegen, a US-based specialist in biotech-enabled fragrances, notably a new class of natural musk raw

Submitted by:

Andrew Warmington

Croda breaks ground in China

Croda International has broken ground for a low-carbon, multi-purpose production facility on a greenfield site

Submitted by:

Andrew Warmington

Semiconductor manufacturing

Sumitomo Chemical works with Tata

Sumitomo Chemical has signed a Memorandum of Understanding with India’s Tata Electronics to explore a

Submitted by:

Andrew Warmington

FramoChem and VanDeMark are separated

VanDeMark separation is complete

Japan’s Hodogaya Chemical has completed the previously announced acquisition of Hungarian API and intermediates producer

Submitted by:

Andrew Warmington